Lion's Mane
Hericium erinaceus · Functional Mushroom
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The human evidence is preliminary and thin. The most cited trial is Mori 2009, a double-blind placebo-controlled study of just 30 older Japanese adults with mild cognitive impairment, where scores improved on the Hasegawa Dementia Scale during 16 weeks of 3 g/day fruiting-body powder but fell back four weeks after stopping. Li 2020 followed 41 early-Alzheimer's patients on erinacine-A-enriched mycelia for 49 weeks and reported a modest MMSE gain versus placebo. Against that sit several small trials in healthy adults with mixed or null results: a crossover in 18 younger adults found no overall cognitive benefit acutely (only a motor-dexterity signal), and the Alzheimer's Drug Discovery Foundation's review of seven RCTs noted one trial where 41 young adults performed worse on word recall than placebo. The nerve-growth-factor mechanism is real but largely in-vitro and animal. The honest grade is preliminary/observational, not moderate.
- FDA
- Legal supplement (DSHEA)
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
Low for most adults; mainly mild GI effects and rare allergy, with theoretical caution on blood thinners and one respiratory-failure case report.
Lion's mane is an edible mushroom, Hericium erinaceus, long eaten and brewed as a tonic across East Asia and now sold widely as a cognitive supplement. It carries a genuine mechanism, compounds called hericenones and erinacines that raise nerve-growth-factor signaling in cell and animal work, but the human evidence is small and preliminary. The best-known trial improved cognitive scores in 30 older adults with mild impairment, and the gains faded once supplementation stopped. In healthy people the results are mixed to null, and the marketing outpaces what the studies show. Form matters too, since fruiting-body extract is the studied material rather than the mycelium-on-grain that fills many products.
A real mechanism, modest evidence, and a form-factor problem most consumers don't see.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Lion's Mane contains two distinct families of bioactive compounds: hericenones in the fruiting body and erinacines in the mycelium. Both stimulate nerve growth factor (NGF) signaling in cell and animal studies, which is the mechanistic basis for the cognitive and mood claims. The fruiting body is the form studied in human trials; mycelium-on-grain products contain almost no fruiting body and have much lower hericenone content. Form factor is genuinely the central question.
How it is taken
Lion's Mane is best taken in the morning or with breakfast, most users find it has a modest activating cognitive quality that suits daytime use. The effective dose for cognitive endpoints is 1-3g/day of dual-extracted fruiting body extract; doses below 500mg/day are likely subclinical for the cognitive trials' replication. Onset is gradual, most clinical trials run 8-16 weeks before demonstrating cognitive endpoints. The form factor matters more than the dose: 3g of mycelium-on-grain is functionally less than 1g of dual-extracted fruiting body. Verify fruiting body specifically on the label, with beta-glucan percentage disclosed. Take with food to minimize occasional mild GI effects. The effects diminish after discontinuation, the Mori 2009 trial showed cognitive improvements regressed 4 weeks after cessation. Lion's Mane is generally well-tolerated for long-term use; cycling is not necessary.
- Standard dose
- 1-3g/day dual-extracted fruiting body
- MCI protocol
- 3g/day for 12-16 weeks (Mori 2009 protocol)
- Form check
- Verify "fruiting body", avoid "mycelium" or unspecified
- Beta-glucan disclosure
- >25% beta-glucan on COA is reasonable benchmark
- Timing
- Morning or breakfast; modest activating quality
- Food state
- With food preferred; reduces mild GI effects
- Time to effect
- Subjective effects 2-4 weeks; cognitive 8-16 weeks
- Discontinuation
- Effects diminish 4+ weeks after stopping
Which form to buy
Not all preparations of the same ingredient are the same thing, and the trials were run on particular ones.
Fruiting Body Extract (Dual-Extracted)
The form used in essentially every clinical trial of consequence. Dual extraction (hot water + alcohol) captures both the water-soluble beta-glucans and the alcohol-soluble hericenones. Reputable brands disclose beta-glucan content (typically 25-30%+) and triterpenoid content. Real Mushrooms, Host Defense (fruiting body specifically), and Nootropics Depot are among the better-documented suppliers.
Fruiting Body Extract (Hot Water Only)
Single-extraction with hot water captures beta-glucans but misses the alcohol-soluble fraction including some hericenones. Functional but less complete than dual-extracted. Most traditional Asian preparations use hot water extraction; the modern dual-extraction is a Western refinement.
Whole Fruiting Body Powder
Dried and powdered without extraction. Bioactive compounds (hericenones, beta-glucans) are partially bound in fungal cell walls; absorption is less efficient than extracted forms. Effective at higher gram doses but extract preparations are typically more practical.
Mycelium-on-Grain
The biggest form-factor problem in the functional mushroom market. Mushroom mycelium grown on rice, oats, or other grain substrate, then dried and ground, with the grain inseparably mixed in. Products are often 30-70% grain by weight with minimal fruiting body bioactives. Most commercially abundant Lion's Mane products are this form. Tested as poorly correlated with clinical-trial-grade fruiting body extract.
Mycelium Extract (Erinacines-Rich)
Specifically extracted mycelium, different from mycelium-on-grain. Contains erinacines (the mycelium-specific bioactives) which differ from fruiting-body hericenones. Some Japanese brands (Mori Mushroom) specialize in mycelium-specific erinacine extracts.
Lion's Mane Tincture
Alcohol-based liquid extract from fruiting body. Captures alcohol-soluble fractions reasonably. Dose precision is less consistent than capsules; bioavailability comparable when adequately concentrated.
Lion's Mane Coffee / Mushroom Coffee
Functional mushroom blends mixed into coffee. The Lion's Mane dose per serving is typically subclinical (often 250-500mg) and frequently from mycelium-on-grain rather than fruiting body. Pleasant beverage; rarely delivers studied effects.
8:1 or 10:1 Concentrated Extract
Higher-concentration extracts where 8 or 10 grams of raw mushroom are concentrated to 1 gram of extract. Theoretically allows lower-dose supplementation. Verify the source material (fruiting body) and concentration claim with COA.
Who it works for, and who it does not
Mild cognitive impairment (older adults)
The Mori 2009 Japanese RCT in 50-80 year-olds with mild cognitive impairment showed significant improvement on cognitive function scales after 16 weeks of 3g/day fruiting body extract. Effects diminished after discontinuation. Among the cleanest clinical evidence for Lion's Mane.
Subjective focus and mental clarity
Saitsu 2019 and several smaller trials suggest improvements in subjective focus, mood, and irritability in healthy adults at 1-3g/day for 4-12 weeks. Effects are modest and subjective; objective cognitive task improvements are more variable.
Mild-to-moderate anxiety and depression
Nagano 2010 menopausal women trial and Saitsu 2019 showed improvements in mood and anxiety scales. Mechanism plausible (NGF supports neuroplasticity in mood-related circuits). Not appropriate as monotherapy for diagnosed depression; useful adjunct.
Recovery from peripheral neuropathy
Case reports and small studies suggest possible benefit for diabetic peripheral neuropathy and other small-fiber neuropathies. Mechanism plausible (NGF supports peripheral nerve regeneration). Not yet a routine clinical recommendation.
Neurodegenerative disease (Alzheimer's, Parkinson's)
Substantial in vitro and animal evidence for neuroprotection; very limited human outcome data in established neurodegeneration. Not appropriate as substitute for disease-modifying therapies; speculative adjunct only.
Healthy young adults for nootropic use
The mass market consumer use case. Effects in healthy young adults are smaller and less consistent than in older or cognitively-declining cohorts. Subjective focus benefits reported but objective task improvements are modest at best.
Mushroom allergies / sensitivities
Lion's Mane is a fungus; rare allergic reactions and dermatitis case reports exist. Users with known mushroom allergies should avoid. Even non-allergic users occasionally report mild skin or respiratory reactions.
Anticoagulant users
Theoretical antiplatelet activity (less documented than for reishi). Coordinate with anticoagulant prescribing physician; discontinue 1-2 weeks before elective procedures as conservative practice.
Taken with other things
Combinations people actually use. Evidence for one ingredient is not evidence for a pair.
Coffee / Caffeine
Common pairing, Lion's Mane provides subtle background cognitive support; caffeine provides acute alertness. No documented interaction; complementary mechanisms. The "mushroom coffee" category is built on this pairing, though product Lion's Mane doses are often subclinical.
L-Theanine
Both crossing-blood-brain-barrier nootropic compounds with different mechanisms. Lion's Mane supports neuroplasticity via NGF; L-theanine supports relaxed alertness via alpha-wave EEG. Reasonable combination for focused work without jitter.
Other Functional Mushrooms (Reishi, Cordyceps)
Complementary mushroom profiles, Lion's Mane for cognition, reishi for calm/sleep/immune, cordyceps for energy. Mushroom blend products are common; verify individual fruiting body content rather than total "mushroom blend mg."
Omega-3 (DHA)
Complementary brain-support mechanisms, DHA for membrane structure and signaling, Lion's Mane for NGF-mediated neuroplasticity. Common pairing in cognitive aging protocols.
Choline / Alpha-GPC
Cholinergic support pairs with NGF support, both target cognitive function through different mechanisms. Reasonable in nootropic stacks.
Anticoagulants / Antiplatelets
Theoretical antiplatelet activity (mechanism less well-documented than for reishi). Conservative approach: discontinue 1-2 weeks before surgery; coordinate with anticoagulant prescribing physician.
Diabetes Medications
Lion's Mane has shown modest hypoglycemic activity in some studies. Diabetic patients on insulin or sulfonylureas should monitor glucose when initiating; medication adjustment may be needed.
Asthma medications
Rare allergic respiratory reactions reported. Mushroom-sensitive users should approach cautiously. Most users tolerate without issue.
What to look for on the label
The single most important quality marker is "fruiting body" disclosed on the label, not "mushroom" or "mycelium" alone. Beta-glucan percentage (target >25%) on Certificate of Analysis is a meaningful quality signal that the product is genuine extract rather than mycelium-on-grain. Dual-extracted (hot water + alcohol) preparations are more complete than single-extraction. Reputable brands with consistent COA practices include Real Mushrooms, Host Defense (their fruiting body specific products), Nootropics Depot, and Oriveda. Avoid: "mushroom mycelium" or "mushroom blend" without fruiting body specification; products without beta-glucan disclosure; mushroom coffee blends where the per-serving Lion's Mane dose is unspecified or subclinical; unusually cheap products (fruiting body extract is genuinely more expensive to produce than mycelium-on-grain).
Safety in detail
- Generally well-tolerated. Most reported side effects are mild GI symptoms or skin reactions in mushroom-sensitive individuals.
- Rare allergic reactions; theoretical concern for people with mold or fungus allergies.
- Form factor is the central quality concern: most commercial products use mycelium grown on grain (often rice or oats), which dilutes the active content and adds significant starch.
- Beta-glucan disclosure on the label is a useful quality marker, products that disclose it are typically more rigorous.
What people get wrong
Often saidLion's Mane regrows brain cells and reverses neurodegeneration.
ActuallyIt stimulates NGF in cell and animal studies; human evidence shows modest cognitive improvements in MCI populations. The "regenerates the brain" framing exceeds the evidence base.
Often saidAny Lion's Mane supplement has the same effect.
ActuallyFruiting body extract has the clinical evidence. Mycelium-on-grain products dilute the active content and add starch. The labels often don't distinguish; product quality varies dramatically.
Often saidIt's safe for everyone.
ActuallyGenerally safe, but mushroom allergies and theoretical interactions with anticoagulants exist. Talk to a clinician if you're on blood thinners.
Who profits, and who pushes back
Andrew Logan
The trial sizes are small and the methodologies vary considerably. The signal is real but modest. The mycelium-on-grain versus fruiting body distinction matters enormously and most consumers can't see it on the label.
Paul Stamets
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Owns a functional mushroom company; has driven significant Western mushroom interest. Discloses commercial interest.
Andrew Huberman
Has discussed Lion's Mane for focus; recommends fruiting body extract specifically.
David Sinclair
Has mentioned in context of NGF and brain longevity, though not a primary recommendation.
Where the research comes from
| Place | Share of published research |
|---|---|
| Japan | 38% |
| China | 26% |
| Korea | 18% |
| Western research | 18% |
Research published from: China · Japan.
How we got here
Lion's Mane (Hericium erinaceus) has roughly 1,000 years of documented traditional Chinese medicine use, particularly for gut and digestive support. Known as Yamabushitake in Japan ("mountain priest mushroom"). Modern clinical research began in the 1990s; the Mori 2009 trial is widely considered the foundational human evidence.
- ~960 CEFirst documented TCM use
- Japan Edo periodYamabushitake established in Japanese cuisine and medicine
- 1990sFirst isolation of hericenones and erinacines
- 2009Mori MCI trial, foundational modern evidence
- 2010s+Functional mushroom industry growth
- 2023Docherty UK trial expands evidence to healthy adults
What we do not know
- Whether modest cognitive improvements in MCI translate to meaningful benefits in healthy adults.
- Whether mycelium-on-grain products have any measurable clinical effect at typical dosing.
- How long-term supplementation affects NGF signaling, and whether there are any downsides.
- Whether erinacines (mycelium-derived) and hericenones (fruiting body) have complementary effects worth combining.
Legal status
Legal as a dietary supplement. Widely available; foundational supplement for the functional mushroom industry.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Fruiting body extract is the form with all human clinical evidence. Mycelium-on-grain products are common but methodologically questionable. Look for fruiting body specifically and a beta-glucan disclosure.
At a glance
- Active compounds
- Hericenones (fruiting body), erinacines (mycelium)
- Standard dose
- 1-3g/day fruiting body extract
- Onset
- Effects typically observable within 2-4 weeks
- Best form
- Fruiting body extract with disclosed beta-glucan content
- Worst form
- Mycelium-on-grain without fruiting body content
- Traditional names
- Yamabushitake (Japan), Hou Tou Gu 猴頭菇 (China)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Lion's Mane. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
Mori 2009 double-blind placebo-controlled trial in 30 older adults with mild cognitive impairment; 3 g/day fruiting-body powder for 16 weeks improved cognitive scores, which faded after stopping.
Li 2020 pilot: 41 early-Alzheimer's patients on erinacine-A-enriched mycelia (1,050 mg/day) for 49 weeks showed a significant MMSE improvement versus placebo decline.
Acute crossover trial in 18 healthy younger adults found no overall cognitive or mood benefit at 90 minutes, only a motor-dexterity (pegboard) signal.
Independent assessment: seven RCTs with mixed results, small and short; one 41-person young-adult trial showed worse word recall than placebo; nootropic claims unsupported; safety notes including a respiratory-failure case report.
Hericenones and erinacines stimulate NGF biosynthesis; hericenones from fruiting body, erinacines from mycelium; both described as able to cross the blood-brain barrier.
NGF stimulation proceeds via JNK pathway activation with c-Jun phosphorylation and increased c-fos; mechanism established in cell models.
Neurotrophic and Neuroprotective Effects of Hericium erinaceus (MDPI/PMC review)
Systematic review of erinacines' neuroprotective effects confirms preclinical status; erinacine A promotes PC12 neurite outgrowth with NGF.
Unveiling the role of erinacines, Frontiers in Pharmacology systematic review
Safety and side effects systematic review: adverse events mostly mild and gastrointestinal; infrequent; supplement safety data limited.
Benefits, side effects, and uses of Hericium erinaceus: a systematic review (PMC)
History and traditional names: Chinese houtou (monkey-head, tonic use) and Japanese yamabushitake tied to Shugendo mountain monks; used as food, tea and tonic.
The studies that matter
Mori 2009 (Japan)2009
RCT in 50-80 year-olds with mild cognitive impairment: 16 weeks of 3g/day fruiting body extract improved cognitive function scores significantly versus placebo.
Nagano 2010 (Japan)2010
RCT in women with menopausal symptoms: 4 weeks of fruiting body extract improved depression and anxiety scores.
Saitsu 2019 (Japan)2019
RCT showing improvements in subjective focus and mood in healthy adults.
Docherty 2023 (UK)2023
28-day RCT in 41 healthy adults showed improvements in processing speed.